Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders by Snircova E., Kulhan T., Nosalova G., Ondrejka I.

Get full text

Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine by Oppa M., Kulhan T., Nosáľová G., Ondrejka I.

Get full text

Is atomoxetine effective in some comorbid mental disorders in ADHD? by Cesneková D., Šnircová E., Nosáľová G., Ondrejka I.

Get full text

Review of a New Multimodal Antidepressant Vortioxetine by Oppa M, Cesnekova D, Nosalova G, Ondrejka I

Get full text

Coexisting Depression and Anxiety: Classification and Treatment by Kulhan T., Ondrejka I., Ordaz J., Snircova E., Nosalova G.

Get full text

Atomoxetine and Methylphenidate Treatment in ADHD by Snircova E., Hrtanek I., Kulhan T., Nosalova G., Ondrejka I.

Get full text

Efficacy of vortioxetine monotherapy compared with combined therapy vortioxetine and olanzapine in the treatment of major depression – first results by Oppa M., Ondrejka I., Cesnekova D., Tonhajzerova I., Nosalova G.

Get full text

Pupillary Light Reflex in Children with ADHD by Hamrakova A, Ondrejka I, Sekaninova N, Peregrim L, Tonhajzerova I

Get full text

Pharmacotherapy of adolescent depression - fluoxetine monotherapy or combined treatment? by Cesneková D., Ondrejka I., Oppa M., Tonhajzerová I., Nosáľová G.

Get full text

Evaluation of Inflammatory Response System (IRS) and Compensatory Immune Response System (CIRS) in Adolescent Major Depression by Ferencova N, Visnovcova Z, Ondrejka I, Funakova D, Hrtanek I, Kelcikova S, Tonhajzerova I

Get full text

Blood Cell Counts and Blood Cell Ratios as Non-Specific Major Depressive Disorder Biomarkers by Krivosova M, Kusnir P, Kertys M, Mestanik M, Tonhajzerova I, Hrtanek I, Ondrejka I, Mokry J.

Get full text